Interestingly, crizotinib treatment in LS141 xenografts showed greater tumor growth than vehicle control perhaps as a result of activation of other RTKs such as increased phospho-c-Kit and phospho-IGF1-R signal seen on western immunoblotting. This evidence concerns the gene IGF1R and neoplasm.